{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:26:09Z","timestamp":1788297969607,"version":"build-2803163510"},"reference-count":47,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T00:00:00Z","timestamp":1558828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Maudsley NHS Foundation Trust and King's College London"},{"name":"National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and King's College London"},{"name":"Pilgrim Trust"},{"name":"Camurus AB"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction and Aims<\/jats:title><jats:p>There has been significant recent investment in new medications for opioid use disorder, including buprenorphine depot injections. Patients and professionals need good quality, independent information on medications to help them make informed treatment decisions. This paper aims to understand patients\u2019 information needs and preferences in relation to buprenorphine depot injections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and Methods<\/jats:title><jats:p>Semi\u2010structured qualitative interviews were conducted with 36 people using opioids (26 men, 10 women; 24\u201363\u2009years). Twelve participants were currently prescribed daily oral methadone; 12 were currently prescribed daily oral buprenorphine; and 12 were using heroin and not in treatment. Interviews were transcribed, coded and analysed via Iterative Categorisation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Participants asked many questions about depot buprenorphine injections. These related to: (i) medication purpose and availability; (ii) pharmacology; (iii) evidence base and effectiveness; (iv) safety and side effects; (v) administration and dosing; and (vi) reducing and ending treatment. Additionally, participants expressed their information preferences in terms of (i) \u2018format\u2019 and (ii) \u2018source\u2019. Specifically, they wanted printed, verbal and electronic materials provided by people in authority, particularly patients who had already had the medication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and Conclusions<\/jats:title><jats:p>All potential patients should be offered accessible information on depot buprenorphine to enable them to consider their options and participate meaningfully in treatment decision making. We recommend that further qualitative research is undertaken to produce informative video material that describes patient experiences of receiving depot buprenorphine. This should help to balance biomedical knowledge with lay knowledge, so facilitating more informed discussions when decisions about depot buprenorphine treatment are made.<\/jats:p><\/jats:sec>","DOI":"10.1111\/dar.12939","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T06:41:06Z","timestamp":1558939266000},"page":"510-518","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences"],"prefix":"10.1111","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-5983","authenticated-orcid":false,"given":"Joanne","family":"Neale","sequence":"first","affiliation":[{"name":"National Addiction Centre Institute of Psychiatry, Psychology and Neuroscience, King's College  London UK"},{"name":"South London and Maudsley NHS Foundation Trust, Maudsley Hospital, Denmark Hill  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte N. E.","family":"Tompkins","sequence":"additional","affiliation":[{"name":"National Addiction Centre Institute of Psychiatry, Psychology and Neuroscience, King's College  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Strang","sequence":"additional","affiliation":[{"name":"National Addiction Centre Institute of Psychiatry, Psychology and Neuroscience, King's College  London UK"},{"name":"South London and Maudsley NHS Foundation Trust, Maudsley Hospital, Denmark Hill  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,5,26]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"SAMHSA. Medication\u2010assisted treatment (2018). Available at:https:\/\/www.samhsa.gov\/medication-assisted-treatment(accessed December 2018)."},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903037168"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.149195"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000456612"},{"key":"e_1_2_8_6_1","unstructured":"WHO\/UNODC\/UNAIDS. Substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS Prevention. Position Paper (2004) Available at:http:\/\/www.who.int\/substance_abuse\/publications\/en\/PositionPaper_English.pdf(accessed December 2018)."},{"key":"e_1_2_8_7_1","volume-title":"Medications in recovery: re\u2010orientating drug dependence treatment","author":"Bell J","year":"2012"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S109331"},{"key":"e_1_2_8_9_1","first-page":"33","article-title":"Drug users\u2019 views of prescribed methadone","volume":"5","author":"Neale J","year":"1998","journal-title":"Drugs"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049732311432718"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2013.04.010"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01348.x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13539"},{"key":"e_1_2_8_14_1","volume-title":"Drug misuse and dependence: UKguidelines on clinical management","author":"Clinical guidelines on drug misuse and dependence update 2017 independent expert working group","year":"2017"},{"key":"e_1_2_8_15_1","article-title":"Patient views of opioid pharmacotherapy bio\u2010delivery systems: qualitative study to assist treatment decision making","volume":"26","author":"Neale J","journal-title":"Exp Clin Psychopharm"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S72543"},{"key":"e_1_2_8_17_1","unstructured":"Food and Drug Administration. FDA approves first once\u2010monthly buprenorphine injection a medication\u2010assisted treatment option for opioid use disorder (2017). Available at:https:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm587312.html (accessed December 2018)."},{"key":"e_1_2_8_18_1","unstructured":"European Medicines Agency. Buvidal\u00ae (2018). Available at:https:\/\/www.ema.europa.eu\/medicine\/summary-opinion\/buvidal(accessed December 2018)."},{"key":"e_1_2_8_19_1","unstructured":"CamurusAB. Buvidal\u00ae weekly and Buvidal\u00ae Monthly (CAM2038) approved in Australia as the first long\u2010acting treatment of opioid dependence (2018). Available at:https:\/\/news.cision.com\/camurus-ab\/r\/buvidal--weekly-and-buvidal--monthly--cam2038--approved-in-australia-as-the-first-long-acting-treatm c2682401(accessed December 2018)."},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.03.057"},{"key":"e_1_2_8_21_1","unstructured":"Food and Drug Administration. FDA takes new steps to advance the development of innovative products for treating opioid use disorder (2018) Available at:https:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm605248.htm(accessed December 2018)."},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2007.9.4\/hkleber"},{"key":"e_1_2_8_23_1","volume-title":"WHO Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Annex 12 prescribing guidelines","author":"WHO","year":"2009"},{"key":"e_1_2_8_24_1","unstructured":"Medicines & Healthcare products Regulatory Agency. Medicines information: SPC & PILs (2018). Available at:http:\/\/www.mhra.gov.uk\/spc-pil\/(accessed December 2018)."},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-137-14397-6"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03283.x"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9566.2012.01528.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-018-4342-9"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(98)00453-5"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9566.00360"},{"key":"e_1_2_8_31_1","first-page":"65","article-title":"Barriers to treatment access and informed patient choice in the treatment of opioid dependence in Europe","volume":"14","author":"Benyamina A","year":"2012","journal-title":"Heroin Addict Rel Cl"},{"key":"e_1_2_8_32_1","first-page":"1408","article-title":"Are we there yet? Data saturation in qualitative research","volume":"20","author":"Fusch PI","year":"2015","journal-title":"Qual Rep"},{"key":"e_1_2_8_33_1","volume-title":"MAXQDA computer programme","author":"VERBI Software","year":"2016"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13314"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/0306312702032001005"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1057\/9780230582569"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2004.11.063"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-007-9148-5"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2017.01.065"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-017-4959-3"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207226"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9566.00185"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.2190\/JL1D-21BG-PK2N-J0KD"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2011.09.040"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1159\/000088581"},{"key":"e_1_2_8_46_1","volume-title":"Drugs, policy and politics","author":"Neale J","year":"2006"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(00)00247-1"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.12.031"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdar.12939","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.12939","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dar.12939","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.12939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T17:18:38Z","timestamp":1694279918000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.12939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,26]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1111\/dar.12939"],"URL":"https:\/\/doi.org\/10.1111\/dar.12939","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,26]]},"assertion":[{"value":"2018-12-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}